Стоит ли избегать trifluoropropyl cyclotrisiloxane при беременности? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

Безопасен ли trifluoropropyl cyclotrisiloxane при беременности?

No EU harmonised CLP (Annex VI) or Annex II/III cosmetic restriction found; supplier safety data sheets list H361 (suspected of damaging fertility or the unborn child) as a notified/self-classification, but no harmonised H360/H361 CLH entry was located on ECHA. No peer‑reviewed reproductive/developmental studies on this specific CAS (2374‑14‑3) were found in PubMed. (ECHA substance page; supplier SDS; PubChem).

Безопасен ли trifluoropropyl cyclotrisiloxane при грудном вскармливании?

Same weight of evidence as pregnancy: no harmonised CMR classification or authoritative cosmetic-safety opinion (SCCS/CIR) found; some suppliers/SDSs notify reproductive hazard H361 but this appears to be company/self‑classification rather than a harmonised EU CLH. No specific data on transfer to breastmilk for this substance in the literature. (ECHA; supplier SDS).

Безопасен ли trifluoropropyl cyclotrisiloxane для кожи малыша?

Hazard evidence mirrors adult (no harmonised CLH; supplier self‑notifications of H361 only). Dermal exposure potential is low-to-measurable for cyclic siloxanes used topically, so exposure for infants is increased because of immature barrier and higher surface‑area‑to‑weight; per your scoring rules adult exposure scored as low (1) and infant exposure increased by +1. No infant-specific toxicokinetic or dermal absorption studies for CAS 2374‑14‑3 were found. (PubChem; supplier SDS; ECHA dossier).

Как VeriMom оценивает trifluoropropyl cyclotrisiloxane?

VeriMom оценивает trifluoropropyl cyclotrisiloxane в 33/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы trifluoropropyl cyclotrisiloxane при беременности?

См. наш список безопасных альтернатив trifluoropropyl cyclotrisiloxane с аналогичной функцией и классификацией без известных рисков.